Biobanking Trends and Forecast
The future of the global biobanking market looks promising with opportunities in the pharmaceutical & biotechnology company and CRO, academic & research institute, and hospital markets. The global biobanking market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are growing demand for genetic testing and precision medicine, rising popularity of preserving newbornsÄX%$%X cord blood stem cells, and emergence of virtual biobanking software.
• Lucintel forecasts that, within the type category, equipment is expected to witness highest growth over the forecast period.
• Within the application category regenerative medicine will remain the largest segment in the forecast period.
• In terms of regions, APAC is expected to witness highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report.
Emerging Trends in the Biobanking Market
The biobanking market is changing currently due to the occurrence of new technologies, the rise of new research, and changing policies. New trends signal movement of biobanks in terms of operations, use of information, and the role played in biomedical research. Such trends are important to those interested in taking advantage of the new, fast developing, biobanking environment.
• Advanced Technologies Adoption: In order to improve data analysis and sample processing, biobanks are integrating sophisticated tools such as high-throughput sequencing, NGS and artificial intelligence among others. These technologies maximize the effectiveness of biobank tasks making it possible to conduct in-depth research to reveal genetic and environmental risk factors of health and diseases including illness and stress.
• Growth of Personalized Medicine: One of the trends of the market is also the old reason of the increasing medic loud demand for those bank data that focus on cure of a certain disease. New populations and new clinical collections are also expanding and biobanks are making possible research into developing individualized therapies and precision medicine. This trend helps to develop more accurate treatment options and improve the efficacy of medical treatment.
• Safeguarding of Data and its Confidentiality: As focus increases with regard to data privacy and security, biobanks have implemented deep-rooted systems for the protection of such data. Adhering to regulatory frameworks like GDPR and HIPAA has become a vision, and biobanks have stepped up into new horizons of data security including the safeguarding of health and biological data and embracing confidentiality.
• Building of Centrally Managed and Region-Wise Located Biobanks: This current trend has been noticed in numerous countries where they are establishing a common bio bank or biobanks with regional offices to enhance population-based studies and other health-related research on a large pop
• Combination of Biobanks and Sharing of Data: More emphasis is made on the increase of the combination, sharing of data, of the biobanks and research institutions. There are emerging partnerships and networks which make it possible for scientists to utilize many datasets, from which a wide array of research can be pursued, speeding up the pace of discovery. This trend increases the worth of biobank resources and allows for more extensive and effective research.
Building of Centrally Managed and Region-Wise Located Biobanks: This current trend has been noticed in numerous countries where they are establishing a common bio bank or biobanks with regional offices to enhance population-based studies and other health-related research on a large pop
Recent Developments in the Biobanking Market
Recent transitions in the biobanking market are characterized by improvement in technological and infrastructural and research parameters. These developmental milestones are likely to revolutionize biobanking as they will offer new perspectives on biological sample collection, handling and analysis for research. Knowledge of these developments is important for the players in the market in order to understand where the market is headed and identify new possibilities.
• Establishment of Large-Scale Biobanks: The establishment of large-scale biobanks like the All of Us Research Program in the U.S. and the European and Asian national biobanks is worth noting. These biobanks focus on harvesting a wide and rich array of biological samples in order to conduct extensive research population projects and customized treatment. They deepen the level of detail which can be addressed and assist cutting edge research in genetics and population health.
• Combining the Various Areas of Genomics with High Throughput Technologies: The combining of genomics and biobanks with high-throughput practices is making a contribution to the development of research effort expansion. The standard operating procedures include high-throughput sequencing and genomic analysis which now allows the in-depth evaluation of genetic materials and how they affect health and disease. This advancement leads to generation of more targeted and effective research, which in turn allows for deeper insights and eradication of even more diseases.
• Biobank Information Management System’s Improvements: The recent trends in biobank data management systems are enhancing the effectiveness and speed with which biobanks are operating. Improved techniques of handling the biorepository data as well as bioinformatics software help in proper structuring, dissecting, and disseminating the Biobank data. These systems facilitate the incorporation of different types of data sets and streamline the workflows, hence improving the research output.
• More Attention is Given to Bioethics and Regulations: More attention is paid towards the ethical and regulatory perspectives of biobanking. There are measures being put in place by biobanks to make sure that ethics and governance principles such as consent, confidentiality and sample handling are being followed. This concern improves the efficiency and reliability of the operations of biobanks and promotes compliance with accepted standards.
• Increasing the Scale of Biobank Networks and Advances in Collaborations: Growing network and collaboration of the biobanks is an interesting trend as the biobanks are ready to collaborate for sharing the resources and data. These collaborations allow making use of the greater and more varied datasets, benefiting from the synergies of research, and speeding the process of science. Embedding biobanks into global networks helps achieving more complete and significant research results.
Important recent advances in the biobanking field such as the creation of population biobanks, adoption of new information technologies, progress in information management, fulfillment of regulative requirements, enlargements of networks are defining the evolution of the markets. These changes broaden the possibilities of conducting biobanking research, facilitate personalized medicine, and bring about progress in healthcare industry as well as in biomedical research.
Strategic Growth Opportunities for Biobanking Market
In the biobanking market, there are several opportunities for growth in terms of the different applications available. By applying these opportunities, stakeholders will be able to enlarge their engagement in and ultimately influence, the research and public health. This overview focuses on the biobanking frameworks growth dynamics and explains the key growth patterns along with prospects for wider applications defined by the domain extension of the market.
• Genomics Research: The trends of Geno-bank initiatives are in increasing the demand for such a facility in the biobanking market. The biobanks provide a variety of the population and a large sample for genomic research. This application promotes research in the fields of genetic polymorphism, disease development, and treatments in disease management. Transferring the care of biobanks is looking to portions of the genomics research will help grow those in other areas of precise and targeted medicine.
• Personalized Medicine: Personalized medicine is a bane for biobanks opportunities and the growth of this segment cannot be overlooked. Biobanks are now positioned to facilitate research with actual biological specimens and detailed clinical history in support of individualized therapies and drug discovery. This application allows a more reliable diagnosis and a treatment that better targets the disease of the patient and further promotes the development of the personalized medicine field.
• Public Health Research: Biobanks are sources of samples essential for the health based research as well as for the epidemiological studies including but not limited to the studies measuring disease occurrence, factors influencing the occurrence of diseases and their control or prevention. Opportunities for growth include enhancing crucial biobank resources for epidemiological and public health approaches. This enhances the ability to solve public health problems as well as design and implement effective health strategies and programs.
• Drug Development and Clinical Trials: Biobanks are the heart of any drug development or any clinical studies, as they offer biological investigation material for all possible needs. Joining such opportunities means cooperation with pharmaceutical and research companies for the needs of drug development and clinical studies. This application hastens the generation of potential drugs while improving the processes of drug development.
• Disease-Specific Biobanks: Developing disease-specific biobanks is another area for growth as constitutive biobanks such as the ones for cancer, cardiovascular diseases, or rare genetic diseases may be set up. These biobanks are beneficial for the investigation of a better understanding of the disease, its biomarkers and its treatment options. This application promotes specific research work, however, further advances the needs of diagnosis and treatment of specific diseases.
Strategic biobanking miscues opportunities emerging in the biobanking market. Genomics research, personalization medicine, public health research, drug development, and disease specific biobanks indicate areas of growing opportunity and impact. Taking advantage of these opportunities engages progress in research, improves individual healthcare and solves significant public health problems.
Biobanking Market Driver and Challenges
The biobanking market is characterized by various drivers and challenges, including, but not limited to, technology, regulation and economy. Stakeholders need to appreciate such drivers and challenges in order to maneuver into the market and harness such opportunities that are ever on the rise.
The factors responsible for driving the biobanking market include:
• Increasing Demand Text for Personalized Medicine: Resent emphasis on personalized medicine is a major booster in the biobanking market. The term “personalized treatment” clearly structures the concept of therapy requiring a great amount of biological and clinical data needs to provide such treatment. Biobanks assist this requirement with their provision of broad, comprehensive and elaborate sample collections to investigate personalized medicine and enhance healthcare services.
• Inclusion of New Areas in Research Initiatives: The demand for biobank resources is increasing because the scope of research initiatives including genomics, epidemiology, and drug development is broadening. Understanding the growth of these research efforts, there is therefore an increasing demand for more biological specimens that are specific as well as easily available and accessible. Biobanks have embarked on the process of increasing the amount of biological specimens that they have and the scope at which they serve different research purposes in order to make meaningful scientific contributions.
• Government and Institutional Funding: Often, funding provided by the government and the institutions for building and biobanking and research related to it constitutes the core growing factor of the market. Funding helps to set up new biobanks and extend existing ones, to improve research work and to help share it. Increased investment in biobanking initiatives helps to create advanced resources during this period of constant research.
• International Collaboration and Data Sharing: International collaboration and data sharing are stimulating the growth of the biobanking market and due to this reason, it is easier to work with larger and more heterogeneous sets of data. Research and knowledge exchange capabilities are opened up through international partnerships and networks. This trend fosters better and faster science as researches that would have taken longer to conduct are made possible by the availability of talent and biobank resources.
Challenges in the biobanking market are:
• Regulation and Ethical Issues: Regulatory and ethical compliance is more than one of the market forces for biobanking. Dealing with policies regarding the data and its protection, consent of parties and sample handling can be a very slow undertaking quite expensive. It is recognized that ethical considerations and regulatory aspects should be met to retain the credibility and integrity of the biobank structure and operational framework.
• Data Security, Protection and Privacy: Data security and privacy related issues are among the biobanking market challenges. Safeguarding very personal health – biological data from leakage and abusive access is an issue. Cybersecurity practice and legal measures should be performed to protect biomass data from harm and ensure public confidence to biobanks and their practices
• Costs and Infrastructure Resource management: Setting up and running biobanks will involve significant financial investments which particularly for small institutions can prove a challenge. One of the major activities that will be required is sourcing funds for equipment, information technology systems as well as human resource while controlling operational costs. Cost containment and proper resource management practices will be critical factors in the achievement of sustainability of biobank.
Further studies have been done to illustrate specific reasons why these three conclusions should be achieved Given, the theoretical base of biobanking has been developed as much of applied sociology of science. Further, the major forces including however not limited to the technological revolution, the personalization trend in the healthcare industry and the growth in the research activity take shape of the biobanking market. Tackling these drivers and Market problems is essential for utilizing growth opportunities, increasing the research possibilities and conquering the changing reality of biobanking.
List of Biobanking Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biobanking companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biobanking companies profiled in this report include-
• Thermo Fisher Scientific
• PHC Holdings
• Becton
• Dickinson and Company
• QIAGEN N.V.
• Merck KGaA
• Avantor
• Cryoport
• Tecan Trading
• Azenta
Biobanking by Segment
The study includes a forecast for the global biobanking by sample type, product & service, application, end use, and region.
Biobanking Market by Sample Type [Analysis by Value from 2018 to 2030]:
• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids
• Biological Fluids
• Human Waste Products
Biobanking Market by Product & Service [Analysis by Value from 2018 to 2030]:
• Equipment
• Consumables
• Services
• Software
Biobanking Market by Application [Analysis by Value from 2018 to 2030]:
• Regenerative Medicine
• Life Science Research
• Clinical Research
Biobanking Market by End Use [Analysis by Value from 2018 to 2030]:
• Pharmaceutical & Biotechnology Companies and CROs
• Academic & Research Institutes
• Hospitals
Biobanking Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Biobanking Market
The biobanking market has evolved positively due to technological advancements, increased research demands, and a focus on personalized medicine. Biobanks play a crucial role in medical research and therapy development by collecting and preserving biological specimens. Insights into the biobanking landscape in the USA, China, Germany, India, and Japan illustrate the scale and direction of the market amid changing policies and technologies.
• United States: In the U.S., biobanking has made significant strides through the integration of high-throughput gene sequencing and bioinformatics. Initiatives like the All of Us Research Program focus on broad data collection to improve services. Increased funding and public-private partnerships are enhancing biobank capabilities and supporting advances in disease therapeutics and research.
• China: China has heavily invested in its biobanking network, driven by government policies aimed at enhancing biotechnological capabilities and healthcare systems. This includes creating large-scale biobanks and forming collaborations with global organizations. China is also working to advance its legislative policies to ensure ethical use and security of biological materials and data.
• Germany: GermanyÄX%$%Xs biobank growth is supported by robust legislation and high standards for handling patient data and bioethics. The German Biobank Node promotes European data collection and sharing for scientific purposes. Recent efforts focus on integrating biobank data with clinical information to enhance research and precision medicine initiatives.
• India: IndiaÄX%$%Xs biobanking segment is developing due to increasing research activities and government support for biomedical initiatives. New biobanks and expansions of existing ones, such as the Indian Genome Variation Consortium, are emerging. The country aims to strengthen infrastructure and data support for genomics, personalized medicine, and public health research through international partnerships.
• Japan: JapanÄX%$%Xs biobanking market is evolving through technological advancements and personalized medicine strategies. Recent developments include large-scale biobanks and partnerships with international counterparts. Japan is also working to integrate biobank data with electronic health records to improve research and clinical care while enhancing regulatory and ethical frameworks.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What is the biobanking market size?
Answer: The global biobanking market is expected to reach an estimated $6.1 billion by 2030.
Q.2 What is the growth forecast for biobanking market?
Answer: The global biobanking market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the biobanking market?
Answer: The major drivers for this market are growing demand for genetic testing and precision medicine, rising popularity of preserving newbornsÄX%$%X cord blood stem cells, and emergence of virtual biobanking software.
Q4. What are the major segments for biobanking market?
Answer: The future of the global biobanking market looks promising with opportunities in the pharmaceutical & biotechnology company and CRO, academic & research institute, and hospital markets.
Q5. Who are the key biobanking market companies?
Answer: Some of the key biobanking companies are as follows:
• Thermo Fisher Scientific
• PHC Holdings
• Becton
• Dickinson and Company
• QIAGEN N.V.
• Merck KGaA
• Avantor
• Cryoport
• Tecan Trading
• Azenta
Q6. Which biobanking market segment will be the largest in future?
Answer: Lucintel forecasts that equipment is expected to witness highest growth over the forecast period.
Q7. In biobanking market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the biobanking market by sample type (blood products, human tissues, cell lines, nucleic acids, biological fluids, and human waste products), product & service (equipment, consumables, services, and software), application (regenerative medicine, life science research, and clinical research), end use (pharmaceutical & biotechnology companies and CROs, academic & research institutes, and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Biobanking Market, Biobanking Market Size, Biobanking Market Growth, Biobanking Market Analysis, Biobanking Market Report, Biobanking Market Share, Biobanking Market Trends, Biobanking Market Forecast, Biobanking Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.